Results 1 to 10 of about 635,290 (190)

Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan. [PDF]

open access: yesOrphanet J Rare Dis, 2019
Tsutsumi S   +10 more
europepmc   +1 more source

Functional capacity of natural killer cells in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients. [PDF]

open access: yesBMC Infect Dis, 2019
Queiroz GAN   +5 more
europepmc   +1 more source

Hodgkin-like adult T-cell leukemia/lymphoma that developed during the follow-up of HTLV-1 associated myelopathy/tropical spastic paraparesis. [PDF]

open access: yesJ Clin Exp Hematop, 2019
Nakaya Y   +11 more
europepmc   +1 more source

An insight to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) pathogenesis; evidence from high-throughput data integration and meta-analysis. [PDF]

open access: yesRetrovirology, 2019
Mozhgani SH   +13 more
europepmc   +1 more source

Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease Activity. [PDF]

open access: yesFront Microbiol, 2018
Sato T   +12 more
europepmc   +1 more source

Three plasma biomarkers of HTLV-1-associated myelopathy/tropical spastic paraparesis

open access: yesRetrovirology, 2011
Taylor Graham P   +8 more
doaj   +1 more source

Dimethyl fumarate as a promising therapeutic candidate for virus-associated myelopathy. [PDF]

open access: yesBrain
Yoshida T   +8 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Home - About - Disclaimer - Privacy